Myers, Stephanie, Bawn, Ruth H., Bisset, Louise C., Blackburn, Timothy J., Cottyn, Betty, Molyneux, Lauren, Wong, Ai-Ching, Cano, Celine, Clegg, William, Harrington, Ross. W., Leung, Hing, Rigoreau, Laurent, Vidot, Sandrine, Golding, Bernard T., Griffin, Roger J., Hammonds, Tim, Newell, David R. and Hardcastle, Ian R. (2016) High-Throughput Screening and Hit Validation of Extracellular-Related Kinase 5 (ERK5) Inhibitors. ACS Combinatorial Science, 18 (8). pp. 444-455. ISSN 2156-8952
Document
-
![[thumbnail of HTS and hit validation of ERK5 Inhibitors.pdf]](https://sure.sunderland.ac.uk/style/images/fileicons/application_pdf.png "HTS and hit validation of ERK5 Inhibitors.pdf")
HTS and hit validation of ERK5 Inhibitors.pdf - Published Version
Restricted to Repository staff only
Abstract
Abstract
The extracellular-related kinase 5 (ERK5) is a promising target for cancer therapy. A high-throughput screen was
developed for ERK5, based on the IMAP FP progressive binding system, and used to identify hits from a library of 57 617
compounds. Four distinct chemical series were evident within the screening hits. Resynthesis and reassay of the hits
demonstrated that one series did not return active compounds, whereas three series returned active hits. Structure−activity
studies demonstrated that the 4-benzoylpyrrole-2-carboxamide pharmacophore had excellent potential for further development.
The minimum kinase binding pharmacophore was identified, and key examples demonstrated good selectivity for ERK5 over
p38α kinase.
| Item Type: | Article |
|---|---|
| Depositing User: | Stephanie Myers |
| URI: | https://sure.sunderland.ac.uk/id/eprint/9285 |
Further Details
More Information
Identifiers
Users with ORCIDS
Catalogue record
Contributors
University Divisions
Subjects
Actions (login required)
Dimensions
DimensionsDownload Statistics
Downloads per month over past year